| Serial Number | 87818679 |
| Word Mark | AREST |
| Filing Date | Friday, March 2, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 8, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, July 31, 2018 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Research and development services in the field of antibodies; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Technical research in the field of pharmaceutical studies; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical product evaluation; Development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Chemical, biochemical, biological and bacteriological research and analysis; Biological research; Scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; Technology research in the field of Pharmaceutical research and development; Research and development in the field of medicine, the prevention, treatment and management of illness, health care delivery; Medical research; Medical laboratories; Medical and scientific research in the field of medicine, the prevention, treatment and management of illness, health care delivery |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 9, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Phanes Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SAN DIEGO, CA 92121 |
| Party Name | Phanes Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | SAN DIEGO, CA 92121 |
| Event Date | Event Description |
| Monday, June 8, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, June 8, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, September 10, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 6, 2019 | EXTENSION 2 GRANTED |
| Friday, September 6, 2019 | EXTENSION 2 FILED |
| Friday, September 6, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, March 13, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 11, 2019 | EXTENSION 1 GRANTED |
| Monday, March 11, 2019 | EXTENSION 1 FILED |
| Monday, March 11, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, September 25, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 31, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 31, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 11, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 25, 2018 | ASSIGNED TO LIE |
| Thursday, June 14, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 14, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, June 14, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 14, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 14, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, June 14, 2018 | ASSIGNED TO EXAMINER |
| Friday, March 9, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, March 6, 2018 | NEW APPLICATION ENTERED IN TRAM |